
Egg yolk, sunflowerPhosphatidylcholine
The phospholipid that makes up most of the colonic mucus layer, and is measurably depleted in UC. A delayed-release PC (LT-02) had three positive Heidelberg trials in chronic active UC (pooled remission odds ratio 9.7), then a 466-patient phase 3 program was stopped for futility in 2023: deep remission 14% on LT-02 versus 13.5% on placebo. It was never sold. Neither supplement here is delayed-release: BodyBio is a liposomal phospholipid complex, Thorne a standard softgel. The biology holds; the trial form does not exist to buy.
Andrew's notes
A 4 rather than a 5 only because of the negative trial. I continue to see good results and have never seen anything negative. I do wonder whether any downside comes from the same kind of oxidative stress we worry about with seed oils. Two products here; neither is a delayed-release formulation, and the one that was (LT-02) was a drug candidate that never reached the market.
- SKU
- KAN-SP600
- Also
- Thorne Phosphatidyl Choline, go.supplementsforibd.com/phosphatidylcholine-2
At a glance
Product options from the guide
go.supplementsforibd.com/phosphatidylcholine
go.supplementsforibd.com/phosphatidylcholine-2
References
- Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005;54(7):966–971.
- Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101–e107.
- Stremmel W, Vural H, et al. Delayed-release phosphatidylcholine is effective for treatment of ulcerative colitis: a meta-analysis. Dig Dis 2021;39(5):508. (3 RCTs, 160 patients; remission OR 9.68.)
- Modified-release phosphatidylcholine (LT-02) for ulcerative colitis: two double-blind, randomized, placebo-controlled trials. Clin Gastroenterol Hepatol 2023. PMID 37806372. (PCG-2 terminated for futility; 466 randomized; deep remission 13.5% placebo vs 14.2% and 9.7% on LT-02.)
READ & SHOP
Explore related supplements
Vitamins & Minerals
Choline
Direct precursor to phosphatidylcholine (F-08). In the multivitamin.
Barrier Repair
L-glutamine
The primary fuel of the small-intestinal lining. Human trials are honest and unflattering: in Crohn's, oral glutamine improved intestinal permeability but no more…
Barrier Repair
Butyrate
Butyric acid itself (not the sodium or calcium salt) in a sustained-release form designed to survive the small intestine and reach the colon, which is the entire…
Options to explore with your care team. These are not a recommendation to take them together. Andrew earns a commission on Fullscript purchases. US shipping only.



